Kurt A. Gustafson
Net Worth
Last updated:
What is Kurt A. Gustafson net worth?
The estimated net worth of Mr. Kurt A. Gustafson is at least $6,824,883 as of 16 Mar 2022. He has earned $151,153 from insider trading and has received compensation worth at least $6,673,730 in Spectrum Pharmaceuticals, Inc..
What is the salary of Kurt A. Gustafson?
Mr. Kurt A. Gustafson salary is $953,390 per year as Executive Vice President & Chief Financial Officer in Spectrum Pharmaceuticals, Inc..
How old is Kurt A. Gustafson?
Mr. Kurt A. Gustafson is 57 years old, born in 1968.
What stocks does Kurt A. Gustafson currently own?
As insider, Mr. Kurt A. Gustafson owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Spectrum Pharmaceuticals, Inc. (SPPI) | Executive Vice President & Chief Financial Officer | 317,259 | $0 | $0 |
What does Spectrum Pharmaceuticals, Inc. do?
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is based in Boston, Massachusetts.
Kurt A. Gustafson insider trading
Spectrum Pharmaceuticals, Inc.
Mr. Kurt A. Gustafson has made 26 insider trades between 2018-2022, according to the Form 4 filled with the SEC. Most recently he sold 16,318 units of SPPI stock worth $11,521 on 16 Mar 2022.
The largest trade he's ever made was exercising 33,692 units of SPPI stock on 11 Jan 2019. As of 16 Mar 2022 he still owns at least 317,259 units of SPPI stock.
Spectrum Pharmaceuticals key executives
Spectrum Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:
- Dr. Francois J. Lebel FRCPC, M.D. (73) Executive Vice President & Chief Medical Officer
- Mr. Keith M. McGahan J.D., L.L.M. (49) Executive Vice President, Chief Legal Officer & Corporation Sec.
- Mr. Kurt A. Gustafson (57) Executive Vice President & Chief Financial Officer
- Mr. Thomas J. Riga (50) Pres, Chief Executive Officer & Director